Unit dose formulations and methods of treating thrombosis with an oral factor Xa inhibitor

Details for Australian Patent Application No. 2007333377 (hide)

Owner Millennium Pharmaceuticals, Inc.

Inventors Sinha, Uma; Hollenbach, Stanley J.; Abe, Keith

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2007333377

PCT Pub. Number WO2008/073670

Priority 60/947,629 02.07.07 US; 60/873,792 08.12.06 US

Filing date 15 November 2007

Wipo publication date 19 June 2008

International Classifications

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 31/4164 (2006.01) - 1,3-Diazoles

A61K 31/435 (2006.01) - having six-membered rings with one nitrogen as the only ring hetero atom

A61K 31/4409 (2006.01) - only substituted in position 4, e.g. isoniazid, iproniazid

A61K 31/4412 (2006.01) - having oxo groups directly attached to the heterocyclic ring

A61K 31/535 (2006.01) - having six-membered rings with at least one nitrogen and at least one oxygen as the ring hetero atoms, e.g. 1,2-oxazines

A61P 7/02 (2006.01) Drugs for disorders of the blood or the extracellular fluid

Event Publications

30 July 2009 PCT application entered the National Phase

  PCT publication WO2008/073670 Priority application(s): WO2008/073670

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007333390-Replacing system hardware

2007333369-Electrospinning process